The global angiography catheters market size was valued at USD 1.75 billion in 2025 and is projected to grow from USD 1.90 billion in 2026 to USD 3.59 billion by 2034, registering a CAGR of 8.3% during the forecast period from 2026 to 2034. North America dominated the angiography catheters market with a market share of 38.5% in 2025.
An angiography catheter is a thin, flexible medical tube used to deliver contrast dye into blood vessels during angiography procedures, allowing clear visualization of arteries and veins through X-ray imaging. These catheters help diagnose and guide the treatment of cardiovascular, neurovascular, and peripheral vascular diseases. The market includes a wide range of diagnostic and interventional catheters used in hospitals, diagnostic imaging centers, and specialized cardiac care facilities.
Download a Free Sample To learn more about this report,
Hydrophilic Coatings Reduce Friction During Complex Vascular Navigation
Angiography catheters market analysis shows catheter surfaces shifting toward hydrophilic coatings that become highly lubricious when exposed to fluids. This transition reduces sliding resistance and supports smoother navigation through tortuous or narrow vessels, improving catheter control during complex procedures. Terumo’s GLIDECATH uses hydrophilic coating technology and is offered in 17 tip shapes for selective vessel access.
Low-Profile Catheters Enable Access Through Smaller Vascular Entry Sites
Smaller vascular access requirements are shifting angiography catheter designs toward reduced outer diameters while retaining sufficient internal space for diagnostic or interventional devices. This transition supports radial procedures through smaller arteries and can reduce the need for larger access sheaths. Terumo’s R2P SLENGUIDE, for example, uses Slender Technology to reduce outer diameter while maintaining a larger equivalent inner diameter and 6 Fr compatibility.
Cardiovascular Disease Burden and Interventional Cardiology Capacity Expansion Drive Market
The high prevalence of cardiovascular and vascular diseases creates a larger patient base requiring diagnostic angiography procedures. Greater use of coronary and peripheral angiography increases hospital requirements for disposable catheter products during diagnostic interventions. Cardiac catheterization laboratories therefore generate recurring procurement needs for angiography catheters. For example, coronary angiography uses diagnostic catheters to deliver contrast media and visualize blocked or narrowed arteries. This procedure volume supports sustained demand for angiography catheters across hospitals and specialized cardiac centers.
Expansion of cardiac catheterization laboratories increases the number of facilities equipped to perform angiographic and interventional procedures. Additional procedural capacity creates recurring demand for diagnostic and guiding catheters across hospitals and ambulatory care centers. Healthcare providers require multiple catheter configurations to accommodate different vascular procedures and clinical requirements. This broader procedural infrastructure strengthens institutional purchasing and supports continued demand for angiography catheter products.
High Catheter Costs and Stringent Sterility Requirements Restrain Market Expansion
High prices for specialized angiography catheters increase the overall cost of diagnostic and interventional procedures. Hospitals and clinics with limited procedure budgets may restrict catheter purchases or favor lower-cost alternatives where clinically suitable. This cost pressure can limit adoption, particularly in price-sensitive healthcare systems.
Strict sterility requirements for angiography catheters require controlled manufacturing, specialized packaging, and extensive quality testing. These requirements add production and compliance expenses while increasing the operational burden for manufacturers. Higher manufacturing costs can raise product prices and constrain adoption across cost-sensitive healthcare facilities.
Single-Use Catheter Programs and Digital Tracking Platforms Offer Growth Opportunities
Hospitals, ambulatory surgery centers, and catheterization laboratories can adopt single-use angiography catheters to simplify infection-control practices and reduce reprocessing requirements. Recurring procurement creates revenue opportunities through repeat catheter sales, institutional contracts, and bundled supply agreements. Manufacturers such as Terumo and Boston Scientific can leverage established catheter portfolios to serve high-volume procedural facilities, contributing to angiography catheter market growth.
Hospitals and catheterization laboratories can use digital tracking systems to monitor catheter inventory, usage, expiration dates, and replenishment needs. Connected inventory management creates revenue avenues through software subscriptions, monitoring services, and integrated supply-management solutions. Such platforms also help facilities reduce product wastage and maintain appropriate catheter availability.
Product Quality Risks and Complex Clinical Requirements Hinder Growth
Device defects can trigger recalls, inventory segregation, and replacement requirements, disrupting supplier relationships and hospital procurement. In August 2026, the FDA issued an early alert for Boston Scientific’s Imager II Angiographic Catheters because of a manufacturing issue that could cause catheter-tip degradation and detachment. Such events can delay product availability and make hospitals more cautious when adopting affected product lines.
Different angiographic procedures require catheter configurations suited to specific anatomy, access routes, and imaging applications, making portfolio development more complex. Manufacturers must manage multiple designs and clinical requirements while maintaining consistent performance across applications. This product fragmentation can increase development timelines and make it harder for smaller suppliers to expand across diverse angiography applications.
The conventional catheter accounted for a share of 47.3% in 2025, due to its established clinical use, reliable performance, broad compatibility with angiographic procedures, and widespread adoption across hospitals and diagnostic centers.
The DEB catheter segment is expected to grow at a CAGR of 8.1% during the forecast period 2026-2034, driven by its ability to deliver antiproliferative drugs directly to the lesion site, support targeted treatment, and reduce reliance on permanent implants. The scoring balloon catheter and cutting balloon catheter segments support market growth through lesion preparation, plaque modification, and treatment of complex or resistant vascular lesions.
Request Customizationto receive a tailored report.
The coronary segment accounted for a share of 45.6% in 2025, owing to the high prevalence of coronary artery disease, widespread use of coronary angiography, and the essential role of angiography catheters in diagnosing and treating coronary blockages.
The oncology segment is expected to grow at a CAGR of 7.9% during the forecast period 2026–2034, fueled by the growing use of minimally invasive catheter-based procedures for tumor diagnosis, embolization, and targeted cancer treatment. The endovascular, neurology, and other segments support market growth through vascular interventions, neurovascular procedures, and diverse diagnostic and therapeutic applications.
The hospitals segment accounted for a share of 62.4% in 2025, supported by the high volume of angiographic procedures, availability of advanced imaging and catheterization facilities, specialized medical professionals, and capacity to manage complex cardiovascular interventions.
The ambulatory surgical centers segment is expected to grow at a CAGR of 8% during the forecast period 2026-2034, propelled by the shift toward minimally invasive outpatient procedures, shorter hospital stays, lower treatment costs, and improved accessibility to specialized angiographic interventions. The specialty clinics segment supports market growth through focused cardiovascular and vascular care, specialized facilities, and targeted diagnostic and interventional procedures.
Speak to an Analystto discuss market opportunities.
The North America angiography catheters market accounted for the largest regional share of 38.5% in 2025. Well-developed cardiac care facilities, advanced interventional cardiology infrastructure, and widespread use of minimally invasive procedures support angiography catheter adoption across the region. The U.S. angiography catheters market is supported by American Heart Association projections of nearly 132 million people living with cardiovascular disease by 2035, reinforcing the need for cardiovascular diagnosis and intervention.
The Canada angiography catheters market benefits from the country’s 2030 goal to reduce premature mortality from non-communicable diseases by one-third through prevention and treatment. These cardiovascular health priorities sustain the need for diagnostic angiography and catheter-based interventions across North America.
Unlock Regional Insightsto access country-level data, & regional trends.
The Asia Pacific angiography catheters market is expected to grow at a CAGR of 8.9% during the forecast period, showcasing the fastest-growing regional market. Expanding cardiac care facilities, improving access to specialized treatment, and wider adoption of minimally invasive procedures are supporting angiography catheter use across the region. The Japan angiography catheters market is supported by national targets to reduce age-adjusted mortality from heart and cerebrovascular diseases by 2030, strengthening the focus on cardiovascular diagnosis and treatment.
The China angiography catheters market is supported by a target to reduce cardiovascular-disease mortality to 190.7 per 100,000 or lower by 2030, while the South Korea angiography catheters market benefits from Health Plan 2030 cardiovascular disease management targets. The India angiography catheters market is supported by the National Programme for Prevention and Control of Non-Communicable Diseases through 2030, sustaining investment in cardiovascular screening, diagnosis, and intervention services.
The Europe angiography catheters market accounted for the largest regional share of 27.4% in 2025. Established hospital networks, advanced cardiovascular care infrastructure, and routine use of catheter-based procedures support angiography catheter adoption across the region. The U.K. angiography catheters market is supported by England’s 2026 cardiovascular framework targeting a 25% reduction in premature heart disease and stroke deaths within a decade, reinforcing investment in cardiovascular diagnosis and treatment.
The Germany angiography catheters market benefits from cardiovascular diseases, accounting for 33.9% of deaths, while the France angiography catheters market is supported by the EU’s Safe Hearts Plan, as cardiovascular diseases cause 1.7 million deaths annually across the EU. These cardiovascular health priorities sustain the need for diagnostic angiography and catheter-based interventions across Europe.
The Latin America angiography catheters market is expected to grow at a CAGR of 7.1% during the forecast period, showcasing the fastest-growing regional market. Better availability of specialized cardiovascular services and improved hospital facilities are supporting the adoption of angiography catheters across the region. The Brazil angiography catheters market is supported by Brazil’s 2021–2030 health plan targeting a one-third reduction in premature noncommunicable-disease mortality by 2030, alongside measures to expand cardiovascular-risk screening and strengthen care for acute coronary syndromes.
Across Latin America, PAHO’s 2025-2030 plan focuses on strengthening cardiovascular disease management and access to higher-level care, supporting continued development of cardiovascular diagnosis and intervention services.
The Middle East and Africa angiography catheters market accounted for the largest regional share of 4.8% in 2025. Wider access to cardiac diagnostic services and improvements in specialized healthcare facilities are supporting the adoption of angiography catheters across the region. The UAE angiography catheters market is supported by the UAE’s target to reduce premature noncommunicable disease deaths by 30% by 2030, strengthening the focus on cardiovascular disease prevention and treatment.
The Africa angiography catheters market benefits from WHO Africa’s 2030 commitment to reduce premature NCD mortality by one-third and expand access to diagnosis and treatment, including through PEN-Plus services across 20 African countries. These healthcare priorities support continued development of cardiovascular diagnostic and interventional services across the region.
The angiography catheters market is moderately consolidated, with established medical device manufacturers, specialized catheter companies, and regional healthcare technology providers competing across cardiovascular and peripheral vascular applications. Medtronic, Boston Scientific Corporation, Terumo Medical Corporation, Merit Medical Systems, and B. Braun Melsungen AG are among the leading players in the angiography catheters market, collectively accounting for an estimated 60%-65% angiography catheters market share.
Established players compete primarily on product quality, clinical performance, catheter design, regulatory compliance, and distribution networks, supported by strong manufacturing capabilities and established relationships with healthcare providers. Emerging players in the angiography catheters market ecosystem compete through cost-effective products, specialized catheter designs, material innovation, and customization, enabling them to address specific procedural requirements and expand their presence in targeted markets.
Customize This Report to Match Your Strategic Objectives
Author's Details
Healthcare Lead
Debashree Bora is a strategic healthcare research professional with nearly eight years of hands on experience in market intelligence, encompassing primary research, secondary research, market estimation, and consulting engagements. She specializes in pharmaceutical, biotechnology, medical devices, healthcare services, clinical trials, and healthcare outsourcing sectors, providing actionable insights on evolving industry trends, regulatory landscapes, competitive dynamics, and market opportunities. Debashree’s research helps global clients evaluate market potential, identify growth opportunities, strengthen commercial strategies, and make informed business decisions.
Breast Implants Market Size, Share, Growth, Analysis, 2034
Continuous Glucose Monitoring Systems Market Size, Share, 2034
Colposcopes Market Size, Share, Growth, Analysis, Report, 2034
Alpha Emitter Market Size, Share, Growth, Analysis, Report, 2034
Bioabsorbable Stents Market Size, Share, Growth, Analysis, 2034
Artificial Cornea and Corneal Implant Market Size, Share, 2034
We are featured on:
sales@straitsresearch.com